Production and characterization of virus-free, CRISPR-CAR T cells capable of inducing solid tumor regression

Abstract

This study leverages virus-free genome editing technology to generate CAR T cells featuring a <i>TRAC</i>-targeted CAR, which could inform manufacturing of CAR T cells to treat cancers, including solid tumors.